Emulate Inc. closes $82M Series E to fund expansion of ‘organ-on-a-chip’ products
TechCrunch
SEPTEMBER 7, 2021
A 2020 review paper in Bioengineering notes the organ-on-a-chip industry was recently valued around $21 million, but could grow to about $220 million by 2025. . And that itself depends a lot on how the FDA views data collected on that platform. . There is evidence the company has worked closely with the FDA in the past.
74 
Let's personalize your content